Famine versus feast: understanding the metabolism of tumors in vivo

被引:148
作者
Mayers, Jared R. [1 ,2 ]
Vander Heiden, Matthew G. [1 ,2 ,3 ,4 ,5 ]
机构
[1] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA 02139 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Broad Inst MIT & Harvard Univ, Cambridge, MA USA
关键词
cancer metabolism; tumor metabolism; cell proliferation; nutrient availability; CANCER-ASSOCIATED FIBROBLASTS; AMINO-ACID-CONCENTRATIONS; GLUTAMINE-METABOLISM; AEROBIC GLYCOLYSIS; PANCREATIC-CANCER; GASTROINTESTINAL CANCER; ALPHA-KETOGLUTARATE; TRANSFORMED-CELLS; GLUCOSE-INFUSION; HUMAN-BLOOD;
D O I
10.1016/j.tibs.2015.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To fuel unregulated proliferation, cancer cells alter metabolism to support macromolecule biosynthesis. Cell culture studies have revealed how different oncogenic mutations and nutrients impact metabolism. Glucose and glutamine are the primary fuels used in vitro; however, recent studies have suggested that utilization of other amino acids as well as lipids and protein can also be important to cancer cells. Early investigations of tumor metabolism are translating these findings to the biology of whole tumors and suggest that additional complexity exists beyond nutrient availability alone in vivo. Whole-body metabolism and tumor heterogeneity also influence the metabolism of tumor cells, and successful targeting of metabolism for cancer therapy will require an understanding of tumor metabolism in vivo.
引用
收藏
页码:130 / 140
页数:11
相关论文
共 114 条
[1]  
ALBRITTON E.C., 1952, STANDARD VALUES BLOO
[2]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[3]   Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC Transporter Using Positron Emission Tomography in Patients with Non-Small Cell Lung or Breast Cancer [J].
Baek, Sora ;
Choi, Chang-Min ;
Ahn, Sei Hyun ;
Lee, Jong Won ;
Gong, Gyungyub ;
Ryu, Jin-Sook ;
Oh, Seung Jun ;
Bacher-Stier, Claudia ;
Fels, Lueder ;
Koglin, Norman ;
Hultsch, Christina ;
Schatz, Christoph A. ;
Dinkelborg, Ludger M. ;
Mittra, Erik S. ;
Gambhir, Sanjiv S. ;
Moon, Dae Hyuk .
CLINICAL CANCER RESEARCH, 2012, 18 (19) :5427-5437
[4]   INDUCTION OF MEMBRANE RUFFLING AND FLUID-PHASE PINOCYTOSIS IN QUIESCENT FIBROBLASTS BY RAS PROTEINS [J].
BARSAGI, D ;
FERAMISCO, JR .
SCIENCE, 1986, 233 (4768) :1061-1068
[5]   18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response [J].
Ben-Haim, Simona ;
Ell, Peter .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) :88-99
[6]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[7]   Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides [J].
Birsoy, Kivanc ;
Possemato, Richard ;
Lorbeer, Franziska K. ;
Bayraktar, Erol C. ;
Thiru, Prathapan ;
Yucel, Burcu ;
Wang, Tim ;
Chen, Walter W. ;
Clish, Clary B. ;
Sabatini, David M. .
NATURE, 2014, 508 (7494) :108-+
[8]  
Blau N., 2003, Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, DOI [10.1007/978-3-642-55878-8, DOI 10.1007/978-3-642-55878-8]
[9]  
Boros LG, 2000, CANCER RES, V60, P1183
[10]   Regulation of cancer cell metabolism [J].
Cairns, Rob A. ;
Harris, Isaac S. ;
Mak, Tak W. .
NATURE REVIEWS CANCER, 2011, 11 (02) :85-95